This is exactly why VRAD and NHWK's futures are very cloudy as public companies. There is no bottom to their prices and the best they can do is see if they can keep prices going down less then 10 percent per year. I agree that both companies provide important services to the radiology community at large, they just aren't great long-term investments given the holes in their business models.